兔抗CHKB-CPT1B多克隆抗体

Background:

The genes CHKB and CPT1B are adjacent on chromosome 22 and read-through transcripts are expressed that include exons from both loci. The read-through transcripts are candidates for nonsense-mediated mRNA decay (NMD) and are unlikely to express proteins.

Applications:

ELISA, IHC

Name of antibody:

CHKB-CPT1B

Immunogen:

Fusion protein of human CHKB-CPT1B

Full name:

CHKB-CPT1B readthrough (NMD candidate)

Synonyms:

CHKL-CPT1B

SwissProt:

Q92523

ELISA Recommended dilution:

5000-10000

IHC positive control:

Human liver cancer and Human gastric cancer

IHC Recommend dilution:

25-100